BOTOTLSJU
RAPT

Board of Trustees of The Leland Stanford Junior University’s RAPT Therapeutics RAPT Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,155
Closed -$1.98M – 44
2022
Q3 		$1.98M Buy
+10,155
New +$1.92M 0.13% 27

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's RAPT Position: Q4 2022 in Review

Board of Trustees of The Leland Stanford Junior University sold out of RAPT Therapeutics (RAPT) in Q4 2022, closing a stake of 10,155 shares — an estimated $1.98M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in RAPT in Q3 2022 and held it in 1 quarter. The position peaked at $1.98M in Q3 2022. 95 funds tracked by Wall St. Rank hold RAPT as of Q4 2022.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining RAPT Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 10,155 RAPT Therapeutics shares in Q4 2022, an estimated $1.98M.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in RAPT Therapeutics in Q3 2022 and held it in 1 quarter.
  • Board of Trustees of The Leland Stanford Junior University's RAPT Therapeutics position peaked at $1.98M in Q3 2022.
  • 95 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2022.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q4 2022, filed 13 Feb 2023.